For a list of peer-reviewed articles our products have been cited in, check out the publications page.
Go
Analysis of Trastuzumab by Maurice
Analysis of Rituximab by Maurice
Analysis of Infliximab by Maurice
Analysis of Golimumab by Maurice
Analysis of Cetuximab by Maurice
Analysis of Bevacizumab by Maurice
Analysis of Adalimumab by Maurice
ProteinSimple offers a range of research tools to study the biological processes that accompany neurological/neurodegenerative disease.
Quick Start Guide to use Waters™ Empower® 3 Chromatography Data Software with Maurice.
Immunotherapy has opened the door to a new era in cancer treatment where dramatically successful and durable responses are being reported. Still, the population of patients who respond are a minority, and this highlights the need for a deeper understanding of the immune response to cancer. To that end, accumulating evidence suggests that the heterogeneous makeup of the tumor microenvironment (TME) is a major contributor to the discrepancies in response observed.
